Shots:
Integrating scintigraphy with therapeutics, radiopharmaceutical companies have emerged profoundly in the past few decades. With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market
With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026. This year,…
TOP 20
Shots:
The technological advancement, shared cost, and the pursuit of combined extensive research are amongst the few pragmatic and mutual benefits that come with collaborations. Moreover, the risks involved in drug development plans get minimalized by opening the doors to new opportunities and commercialization
When it comes to life science collaborations, companies seek beyond the…
Shots:
Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Apart from the exposure and capital raise, companies gain more recognition, credibility, and indispensable value assessment
2022 had been a great year when it comes to the IPOs of healthcare companies. Bausch…
Shots:
Mergers and Acquisitions are among the predominant elements of the Biopharma Industry. Owing to the repercussions of the Russia-Ukraine war and the ongoing COVID-19 pandemic, the IPOs, public markets, anti-trust law reforms by the US FTC, and M&As among others were relatively low in the biopharma sector in the year 2022Â
In the year…
Shots:
The Animal Health industry plays a vital role in safeguarding animal husbandry and has experienced an evolving change over the years from disease control and treatment activities to a complete healthcare providerÂ
As the bond between owners and their animal companion strengthens, the Animal Health industry foresees an exponential growth in the near future.…
Shots:
The pharmaceutical companies have shown continual efforts towards developing enhanced and innovative treatment options to address the unmet needs of patients with disease eradication being the goal of developing these treatments
Advancements in cellular and molecular biology have increased the possibilities for generating new pharmaceutical products imposing major impacts on the prevention, diagnosis, and…
Shots:
With an increased price range and the lack of accessibility of branded products, the generic version of these products has been established to be more affordable and accessible to patients, providers, and the healthcare system. Therefore, Generic medicines are a bioequivalent substitute for a marketed brand-name drug, developed after the expiry of the patent…
Shots:
Oncology focuses on the study, diagnosis, prevention, and treatment of cancer based on the treatment option and it’s divided into 3 major areas including medical oncology, radiation oncology, and surgical oncology
The advancements in cell and gene therapies have provided pharmaceutical companies with a unique set of ground-breaking tools for the development of more…
Shots:
Immunology focuses on analyzing all aspects of the immune system in both healthy and diseased states, from its structure & function to its disorders, blood banking, immunization & organ transplant
Along with the enhanced utilization of immunotherapies for immunological & autoimmune diseases, monoclonal antibodies have also showcased a great potential to be used as…
Shots:
The past few years have shown an accelerated development in the digital therapeutics market through various applications, tracking devices, and telemedicine being integrated into digital therapies
Digital therapeutics provided powerful tools to maintain the public healthcare system during the Covid-19 pandemic for the people to access treatments for both physical & psychological conditions at home…

